INTRODUCTION
Cap polyposis (CP) is a rare kind of polyposis, which was rst described by Williams et al in 1985 [1] and named as such for the characteristic "cap" of granulation tissue covered by brous purulent exudate. Most of the reported CP cases were seen in women in their 50s, and the polyps were mainly located in the rectum and sigmoid colon. No standard therapy has been implemented for CP. However, metronidazole, steroids, Helicobacter pylori e r a d i c at i on an d s u rg i c a l resection have been tried. Here, we report an interesting case of CP remission by betamethasone enema a er antibiotics therapy including H. pylori eradication, followed by improvement of hypoproteinemia.
CASE REPORT
A 58-year-old woman who had been experiencing frequent bloody mucus diarrhea for 6 months was admitted to another hospital in May 2012. She had a medical history of appendectomy at 12 years and ovariectomy at 57 years of age. She did not usually strain on defecation. She had no smoking and alcohol habits, and no allergic predisposition or history of overseas travel. Colonoscopy revealed multiple mucus-capped reddish polypoid lesions from the rectum to the sigmoid colon. Metronidazole 500 mg/day was administered under the suspected diagnosis of amoebic dysentery but failed to induce a remission. In October 2012, the patient was referred to our hospital.
At the rst visit, her height was 162 cm, weight was 46 kg, and body temperature was 36.3 0 C, with no history of fever. Her body weight had decreased by 6 kg in the past year. e results of other physical examinations, including the chest, abdomen, and skin were normal, and no pedal edema was observed. She had bloody mucus diarrhea, voiding more than 20 times daily.
Laboratory examination results are shown in Table I . e total serum protein level was decreased, and the transaminase level was elevated. Serum samples were positive for anti-H. the same as those reported in the previous hospital (Fig.  1A) . Pathological examination of biopsy samples obtained from polyps showed in ammatory cell permeation in the lamina propria, and the tuber comprised hyperplastic glands.
e tumefactive surface was covered with brous purulent exudate and in ammatory granulation tissue, and decreased goblet cell mucus secretion was observed in the crypt. e eosinophil in ltration was slight compared with that of the lymphocyte and plasma cells (Fig. 2) . Capsule endoscopy revealed no speci c ndings in the small intestine. e passage time through the small intestine was 6 hours. Cap polyposis was diagnosed based on the colonoscopic and pathological ndings.
Because of the patient's positive H. pylori status, H. pylori eradication therapy (60 mg of ransoprazole, 1500 mg of amoxicillin, and 800 mg of clarithromycin daily for 7 days) was initiated 10 days a er her rst visit. Next, levo oxacin was administered as bacterial colitis was suspected, but her symptoms did not improve. Twenty days a er the H. pylori eradication therapy, daily administration of 3 mg betamethasone enema was initiated. Her clinical symptoms improved immediately and stool frequency decreased to 1 or 2 times per day, without bloody diarrhea, 7 days a er the therapy. Colonoscopy showed that the number of polyps decreased a er 2 weeks (Fig. 1B) , and most of them disappeared a er 6 weeks (Fig. 1C) . Considering that the results of the biochemical examinations, including total protein, albumin, AST, and ALT levels, were normalized a er 7 weeks, betamethasone enema was administered once a week. A er 30 weeks, her body weight returned to that before the onset of the symptoms (i.e., 52 kg), and the colonoscopy revealed almost normal ndings (Fig. 1D) . erefore, the betamethasone enema was discontinued, and the patient had no relapse for more than 6 months therea er. In addition, her urea breath test 5 months a er the H. pylori eradication therapy was negative.
DISCUSSION
Cap polyposis is a rare, distinct in ammatory polyposis o en seen in the sigmoid colon and rectum. Its etiology is still unclear, but some causes such as lower colonic mucosal prolapse, abnormal colonic motility [2] , infection [3] , and immune disorder have been suspected. Clinical manifestations include diarrhea, bloody stool, abdominal pain, and body weight loss, and some CP patients show edema and ascites due to hypoproteinemia by protein leakage from the intestinal tract [4] . e in ammatory reactions, C-reactive protein (CRP) levels or white blood cell counts are mostly within the reference range [4] . A previous study reported hypoproteinemia in 78% of CP patients and considered that it re ects disease activity [5] . In our case, CRP was negative and the hypoproteinemia that was observed at the onset improved along with the improvement in symptoms.
In the 67 CP cases from 1986 to 2013, identified by searching MEDLINE and the Ichushi web site by the Japan Medical Abstracts Society, using the keyword "cap polyposis, " the mean age was 49 years (range, 7-79 years) and 46 patients (approximately 70%) were female. Most of the polypoid lesions were located in the region between the rectum and the sigmoid colon, but they were observed in the cecum in some cases [6] . Colonoscopy revealed multiple polyps with white mucus attached to the top, circling a colonic fold, which appear as caterpillar or octopus wart-like formations. is feature suggests that the mucosa between the polyps is normal, o en appearing as a white spot around a polyp. Cap polyposis has characteristic pathological ndings indicating that polyp surface is covered by an in amed granulation tissue "cap" with bromuscular obliteration of the lamina propria. Blood vessel hyperplasia and extension, epithelium cell atrophy, and elongated and tortuous infection with crypts are also observed [7] . Mucosal prolapse syndrome, infection with Entamoeba histolytica, ulcerative colitis, and other polyposis should be mentioned as di erential diagnoses. Cap polyposis can be diagnosed by its characteristic colonoscopic and pathological ndings. However, some cases of CP are diagnosed only by examination of an operation specimen [8] .
Treatment of CP includes sulfasalazine (SPSA), 5-aminosalicylic acid (ASA), transorally or anally administered steroids, metronidazole, new quinolone, H. pylori eradication therapy, and in iximab. Table II presents the treatment success rates in 66 CP cases that were previously described. Some cases were cured spontaneously but the time for remission was 2 months to 9 years. Although the oral SPSA/5-ASA preparation was used in many cases, the results did not support its e cacy. Meanwhile, H. pylori eradication therapy, which was rst described by Oiya et al [9] , was successful in all the cases, and no recurrence has been reported. e reason for the e cacy of eradication therapy is still unknown. H. pylori was not detected in the colonic mucosa on immunohistochemical analysis using an anti-H. pylori antibody [3] . Some authors hypothesized that its e cacy may be due to other bacteria reacting to the H. pylori eradication therapy or to a systemic Fig. 2 . In ammatory cells in ltrate the lamina propria, and the tuber comprises hyperplastic glands. Surface covered with brous purulent exudate and in ammatory granulation tissue; decreased goblet cell mucus secretion in the crypt (H&E x100). e intervals from eradication therapy to symptom relief and polyp disappearance were 3 days-1 month and 2-14 months, respectively [10] [11] [12] [13] [14] .
Although surgery is the next option for cases refractory to treatment, it is necessary to be careful when selecting it, as Tokunaga et al [15] reported its e ectiveness to be only about 55%.
In the present case, the patient did not have a habit of straining at defecation and observation was not acceptable because of her serious symptoms. Furthermore, H. pylori eradication therapy was considered ineffective 20 days a er the treatment. As indicated in Table II , the e cacy of steroid enema is superior to that of systemic administration.
erefore, steroid enema might be the optimal treatment for CP patients a er H. pylori eradication or metronidazole therapy.
CONCLUSION
We have reported our experience with a patient with cap polyposis, who showed a complete response to betamethasone enema. e betamethasone enema is strongly recommended to patients with cap polyposis a er H. pylori eradication or metronidazole therapy.
